FF
BIIB icon

Fluent Financial’s Biogen BIIB Stock Holding History

Fluent Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,144
Closed -$3.37M – 44
2025
Q4 		$3.37M Sell
19,144
-6,399
-25% -$1.05M 1.28% 27
2025
Q3 		$3.58M Buy
+25,543
New +$3.45M 1.4% 23
2022
Q1 		– Sell
-3,583
Closed -$860K – 71
2021
Q4 		$860K Buy
+3,583
New +$921K 0.35% 49

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fluent Financial's BIIB Position: Q1 2026 in Review

Fluent Financial sold out of Biogen (BIIB) in Q1 2026, closing a stake of 19,144 shares — an estimated $3.37M sold.

Fluent Financial first reported a position in BIIB in Q4 2021 and held it in 3 quarters. The position peaked at $3.58M in Q3 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Fluent Financial reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Fluent Financial sold 19,144 Biogen shares in Q1 2026, an estimated $3.37M.
  • Fluent Financial first reported a position in Biogen in Q4 2021 and held it in 3 quarters.
  • Fluent Financial's Biogen position peaked at $3.58M in Q3 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Fluent Financial's 13F filing for Q1 2026, filed 15 Apr 2026.